stockrowWhat it does
BrightSpring Health Services provides pharmacy and healthcare services to people with complex medical needs, largely in their homes and communities. Its patients include older adults, people with chronic illnesses and people who need specialty or behavioral care. Jon Rousseau is its chief executive officer.
The business has two parts. Pharmacy Solutions supplies and supports medications for patients at home, in clinics and in facilities such as senior living communities. Its services include home and community pharmacy, specialty medicines and infusion therapy, where medication is administered intravenously. Pharmacists and nurses help patients manage treatment, while specialty pharmacy teams also help with insurance access and coordinate with physicians.
Provider Services supplies care rather than medication. It includes home health, hospice, rehabilitation, primary care and support with daily activities. For example, a patient recovering from illness may receive clinical care at home, while a patient with a brain injury may receive physical, speech or occupational therapy. BrightSpring also offers home-based primary care and medication management to help coordinate services for patients who need both.
The company serves patients covered by Medicare, Medicaid and commercial insurance, among others. Its Community Living business, which included services for people with intellectual and developmental disabilities, was divested on March 30, 2026.
How it makes money
BrightSpring generates revenue from pharmacy and provider services paid for through government programs, commercial insurers and other sources. Some patients receive both types of service. Many have chronic conditions, and the company says the vast majority receive services on a recurring basis over long periods.
Revenue: $12.9 billion in fiscal 2025; $4.2 billion in the third quarter of 2026.
Pharmacy Solutions generated $11.4 billion in fiscal 2025. It fills prescriptions and provides medication-related services for patients in homes and community settings. Its specialty business handles infused, injectable and oral therapies, including oncology drugs, while its home and community business supplies medications to customers such as senior living communities and hospice patients. The specialty business also provides pharmaceutical services, including fee-for-service and hub programs.
Provider Services generated $1.5 billion in fiscal 2025. Its clinical services include home health, hospice and rehabilitation; its supportive services help with daily activities. The company also provides home-based primary care. It pursues value-based care arrangements, including accountable care organization shared-savings arrangements and contracts with government or managed care entities.
Pharmacy services are delivered under customer and payer contracts, while provider services are subject to government and private-payer reimbursement rules. Rates and billing depend on the service and the applicable arrangement. In the third quarter of 2026, Pharmacy Solutions revenue was $3.7 billion and Provider Services revenue was $481 million. Community Living was excluded from continuing operations in the 2025 and 2024 results.
| Product or service | Revenue, FY2025 | Share | Change on the year |
|---|---|---|---|
| Medicare Part D | $4.1 billion | 28.5% | 28.0% |
| Commercial Insurance | $3.3 billion | 23.0% | 30.7% |
| Medicare Part C | $2.4 billion | 16.8% | 44.9% |
| Medicaid | $1.5 billion | 10.4% | 28.2% |
| Services | $1.5 billion | 10.2% | 11.1% |
| Medicare Part A | $1.1 billion | 7.61% | 9.47% |
| Private and Other | $424.1 million | 2.95% | 2.17% |
| Medicare Part B | $82.8 million | 0.58% | −13.7% |
Customers and how it sells
BrightSpring operates across all 50 states and serves over 465,000 patients daily. Its pharmacy and provider services are both present in 40 states. Approximately 53% of revenue came from 10 states for the year ended December 31, 2025.
Patients include older adults with multiple medications, people receiving hospice care, patients with complex conditions such as cancer, and people needing rehabilitation after neurological injuries. Services reach patients in individual homes, group homes, clinics, senior living communities and skilled nursing and rehabilitation facilities.
The pharmacy business also serves organizations that care for these patients. It filled over 43 million prescriptions in 2025, serving approximately 6,600 customer locations and approximately 73,000 individual or group homes through over 4,500 unique customer and payer contracts. Local pharmacies can deliver medications to customer locations multiple times a day and provide around-the-clock service when needed.
BrightSpring works with health plans, hospitals, physicians and other providers. It also provides bundled or coordinated services to institutions and payers that need more than one type of care. Medicare, Medicaid and commercial insurance cover much of the patient population.
| Segment | Revenue, FY2025 | Share | Change on the year |
|---|---|---|---|
| Pharmacy Solutions | $11.4 billion | 88.7% | 30.7% |
| Provider Services | $1.5 billion | 11.3% | 11.1% |
Suppliers and costs
BrightSpring buys medications and supplies services through pharmacies, clinical teams and other staff rather than manufacturing the therapies it dispenses. Pharmaceutical manufacturers select its specialty pharmacy to distribute and support certain oncology drugs, sometimes exclusively or alongside a small group of pharmacies.
The company uses its scale in drug purchasing and supplier contracting. Its pharmacy model also requires local facilities, delivery operations, technology, pharmacists, nurses and patient-support teams. Provider Services relies on physicians, nurses, therapists, caregivers and other personnel. BrightSpring competes for these workers and invests in recruiting, training, compensation and benefits.
The company had over 23,500 full-time equivalent employees as of December 31, 2025. Its operations also require spending on compliance, quality oversight and systems. BrightSpring continues to invest in technology and process improvements, including medication review, documentation and hiring systems. Its principal historical uses of cash have included acquisitions, debt service and working capital.
- Revenue$12.9B
- Cost of revenue−$11.4B
- Selling, general and administrative−$1.2B
- Operating income$295.3M
Competitive position
BrightSpring competes with local, regional and national pharmacies, as well as other providers of home and community care. In infusion and specialty pharmacy, named competitors include Option Care Health, Coram CVS/specialty infusion services, Accredo and Optum Specialty Pharmacy. In home and community pharmacy, it competes with Omnicare and with some facility owners that provide their own pharmacy services.
The company says competition for pharmacists, nurses, therapists and other qualified personnel is also significant. Competitors vary by service and local market; BrightSpring says no single company competes with it across all its pharmacy customer and patient types.
Our reading: Its local pharmacy network and purchasing scale provide a meaningful competitive advantage where customers need frequent deliveries or in-person service, although regional and national pharmacies compete for those contracts. Our reading: Manufacturer-selected specialty drug relationships provide another advantage in particular therapies, but access is often shared with other pharmacies rather than exclusive.
Our reading: The combination of pharmacy and provider services can help BrightSpring serve several needs of the same patient, but its ability to extend that advantage depends on staffing, execution and contracts with payers and providers.
| Competitor | Where they compete | Threat (our reading) |
|---|---|---|
| Option Care Health, Inc. | Home infusion and specialty pharmacy | High |
| Coram CVS/specialty infusion services | Home infusion and specialty pharmacy | High |
| Accredo Health Group, Inc. | Home infusion and specialty pharmacy | High |
| Optum Specialty Pharmacy | Home infusion and specialty pharmacy | High |
| Omnicare, Inc. | Home and community pharmacy | High |
Growth opportunities
BrightSpring is expanding specialty pharmacy, infusion and provider services, including through acquisitions and new locations. It sees opportunities to provide pharmacy services to more of its provider patients and to offer multiple services to patients moving between care settings. It is also expanding virtual primary care for higher-risk and rural patients and for homebound patients discharged from facilities.
In the third quarter of 2026, specialty and infusion revenue grew 34% from the prior year, supported by prescription growth and limited-distribution drug launches. BrightSpring launched 7 limited-distribution drugs in the quarter, bringing its year-to-date launches to 19, and was supporting 162 in total. The company continues to invest in infusion suites, clinic upgrades and additional therapeutic categories.
Home health growth includes new locations and acquired Amedisys/LHC branches. Those branches contributed $76 million in revenue in the third quarter of 2026. BrightSpring said their integration, particularly in information technology and back-office operations, had performed as expected.
For 2026, BrightSpring expects revenue of $15.9 billion to $16.125 billion and adjusted EBITDA of $850 million to $860 million, excluding Community Living and acquisitions not yet closed. It also expects at least 15% to 20% organic adjusted EBITDA growth in 2027. These are company expectations, not guarantees.
- $6.7BFY2021
- $7.7BFY2022
- $7.7BFY2023
- $10.1BFY2024
- $12.9BFY2025
- $15.9BFY2026 guidance
Structural risks
- Reimbursement and policy: Changes to government payment rates, coverage criteria, prior authorization or payment timing can affect the services BrightSpring provides and the amounts it receives. In the third quarter of 2026, home and community pharmacy revenue fell 6% year over year, including an approximate $50 million impact from the Inflation Reduction Act and the exit of some uneconomic customers.
- Regulation and compliance: The company is subject to healthcare, billing, licensing and dispensing rules. Violations can lead to fines, loss of licenses or exclusion from government payer programs.
- Staffing and competition: BrightSpring competes for pharmacy professionals, clinicians and caregivers. An inability to recruit or retain qualified staff could affect its ability to serve patients and grow.
- Drug supply and costs: Drug inflation, manufacturing or supply problems, product withdrawals and regulatory restrictions can affect pharmacy operations.
- Debt and cash requirements: Debt service uses cash that would otherwise be available for operations and opportunities. Credit agreements also impose operating and financial restrictions.
- Cybersecurity: Cyberattacks could interrupt services or result in unauthorized access to sensitive and personal information.
Bottom line
Our reading
BrightSpring combines a pharmacy business with home and community care for patients who often need services over long periods. Its national footprint, local delivery network and specialty-drug relationships support that model, while reimbursement changes, staffing needs and debt service remain important constraints. Growth depends in part on expanding services to existing patients and integrating acquired operations.